≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Melanoma in situ of other and unspecified parts of face

DOID EFO Endpoint Browser

CD2_INSITU_MELANOMA_FACE

melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

360

4. Check minimum number of events

None

360

5. Include endpoints

None

360

6. Filter based on genotype QC (FinnGen only)

360

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 360 182 178
Unadjusted period prevalence (%) 0.07 0.06 0.08
Median age at first event (years) 72.56 71.12 74.04

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
316
Matched controls
3162
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
+∞
323.0
305
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
63.0
196.5
251
182
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
12.4
71.3
147
207
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
764.5
65.3
62
*
ZZR00
NOMESCO Finland
Flap of skin
29.6
56.7
77
34
L57.0
ICD-10 Finland
Actinic keratosis
8.7
55.4
142
272
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
10.6
41.0
85
106
D03.30
ICD-10 Finland
Melanoma in situ on the lip
+∞
40.5
38
*
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
22.1
33.5
49
26
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
69.5
32.8
37
6
TQW99
NOMESCO Finland
Other minor procedure on skin
8.7
31.9
73
105
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
6.7
29.7
83
160
S18
ICPC
Laceration/cut
3.9
28.7
216
1122
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.7
28.3
114
336
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
307.3
28.2
28
*
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
9.6
23.4
49
59
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
12.9
23.0
41
36
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.4
19.3
62
137
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
9.0
18.7
40
50
D06BB10
ATC
imiquimod; topical
6.3
18.2
50
91
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
70.9
17.9
20
*
ZZA50
NOMESCO Finland
Full thickness skin graft
39.2
17.9
22
6
SPAT1153
SPAT
Removal of sutures
2.8
16.6
158
830
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
9.8
16.4
33
37
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
7.0
15.6
39
62
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
8.4
15.1
33
43
ZXC20
NOMESCO Finland
Use of chemical agents
10.5
15.0
29
30
DHB00
NOMESCO Finland
Excision of lesion of external nose
13.7
13.6
23
18
L82
ICD-10 Finland
Seborrhoeic keratosis
2.9
12.6
87
363
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
4.0
12.6
53
152
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
6.6
12.5
32
53
WX110
NOMESCO Finland
Local anesthesy
2.4
12.1
226
1603
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
48.6
12.0
14
*
S77
ICPC
Malignant neoplasm of skin
13.3
11.8
20
16
PJA12
NOMESCO Finland
Sentinel node biopsy
4.4
11.8
44
113
ZXC50
NOMESCO Finland
Cryotherapy
5.3
11.7
36
75
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
67.5
11.7
13
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
5.0
11.4
37
82
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
21.0
11.2
16
8
I78.1
ICD-10 Finland
Naevus, non-neoplastic
10.6
11.2
21
21
Z2221
NOMESCO Finland
Medical doctor
2.4
11.0
120
642
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
8.5
10.8
23
29
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
7.2
10.6
25
37
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
24.3
10.3
14
6
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
9.6
10.2
20
22
ZZA00
NOMESCO Finland
Split skin graft
6.3
10.1
26
44
D03.5
ICD-10 Finland
Melanoma in situ of trunk
27.0
9.9
13
5
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
6.7
9.8
24
38
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
56.8
9.7
11
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
18.2
9.5
14
8
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
103.0
9.5
10
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.2
8.9
27
56
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
13.2
8.5
14
11
J01DB01
ATC
cefalexin; oral
2.3
8.2
260
2112
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
7.6
8.1
18
25
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
13.5
7.9
13
10
WX002
NOMESCO Finland
Sedation and analgesia
2.2
7.6
93
510
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
12.3
7.6
13
11
S82
ICPC
Naevus/mole
2.6
7.4
58
253
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
11.2
7.4
13
12
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
9.7
7.4
14
15
8742/2-C44.3
ICD-O-3
Lentigo maligna of skin of other and unspecified parts of face
+∞
7.3
7
*
8742/3-C44.9
ICD-O-3
Lentigo maligna melanoma of skin, NOS
+∞
7.3
7
*
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
7.3
7
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
7.0
6.9
16
24
ZQZ00
NOMESCO Finland
Treatment of several skin areas
11.3
6.9
12
11
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
9.6
6.8
13
14
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
23.1
6.7
9
*
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
11.3
6.3
11
10
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
18.5
6.3
9
5
8742/3-C44.3
ICD-O-3
Lentigo maligna melanoma of skin of other and unspecified parts of face
+∞
6.3
6
*
D22
ICD-10 Finland
Melanocytic naevi
5.1
6.2
18
37
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
8.9
6.1
12
14
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
10.3
6.1
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
173
397
7.46
79.80
1.8
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
282
1199
7.24
62.45
4.5
2.3
—
—
—
0
0
(4035726)
95
286
4.15
28.50
1.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
62
143
5.03
25.97
1.4
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
336
2712
4.58
13.76
20.1
17.1
ml/min/173m2
70.8
71.7
0.34
280
2257
(3010813) Leukocytes [#/volume] in Blood
351
3086
6.49
12.48
30.8
25.9
e9/l
6.7
6.8
0.74
339
2978
(3033658) Prothrombin time (PT) actual/Normal
131
793
2.02
8.91
4.7
3.8
%
81.9
85.8
0.95
126
779
(3007461) Platelets [#/volume] in Blood
350
3085
5.84
8.89
31.0
25.8
e9/l
238.6
240.2
0.17
338
2991
(3035941) MCH [Entitic mass]
350
3086
5.83
8.86
30.7
25.7
pg
30.4
30.4
0.04
341
3021
(3026361) Erythrocytes [#/volume] in Blood
350
3086
5.83
8.86
30.8
25.8
e12/l
4.4
4.4
0.48
337
2978
(3024731) MCV [Entitic volume]
350
3086
5.83
8.86
30.7
25.8
fl
91.6
91.7
0.24
341
3021
(3000963) Hemoglobin [Mass/volume] in Blood
350
3086
5.83
8.86
31.0
26.0
g/l
132.5
132.1
0.16
341
3018
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
334
2862
3.31
8.75
19.5
17.6
mg/l
24.0
25.7
0.38
264
2348
(3019550) Sodium [Moles/volume] in Serum or Plasma
346
3037
4.58
8.56
24.8
21.0
mmol/l
139.3
139.6
1.03
335
2945
(3023103) Potassium [Moles/volume] in Serum or Plasma
346
3041
4.54
8.46
25.6
21.1
mmol/l
4.0
4.0
1.11
336
2948
(3009542) Hematocrit [Volume Fraction] of Blood
295
2415
2.23
7.99
23.8
19.3
%
39.4
38.3
1.32
189
1458
(42870588) Differential panel, method unspecified - Blood
155
1026
1.90
7.91
6.2
5.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
191
1354
1.87
7.85
6.5
5.4
%
0.7
0.6
0.42
162
1258
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
325
2784
2.72
7.75
5.4
4.9
mmol/l
4.4
4.4
0.12
290
2490
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
323
2760
2.66
7.72
5.4
4.8
mmol/l
1.5
1.5
0.70
286
2443
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
315
2662
2.47
7.70
4.6
4.3
mmol/l
1.2
1.2
0.46
276
2339
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
342
3016
3.68
7.61
13.3
11.3
u/l
22.9
23.4
0.31
325
2879
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
126
790
1.92
7.51
1.7
1.6
mmol/l
1.3
1.3
0.30
98
636
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
331
2874
2.88
7.44
6.2
5.6
mmol/l
2.5
2.5
0.17
298
2561
(3019069) Monocytes/100 leukocytes in Blood
193
1395
1.83
7.25
6.6
5.6
%
9.1
8.8
0.97
165
1298
(3006504) Eosinophils/100 leukocytes in Blood
192
1387
1.82
7.21
6.5
5.4
%
2.6
2.8
0.37
163
1286
(36304419) Bacteria [Presence] in Urine
141
927
1.86
7.19
4.0
3.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
313
2660
2.35
7.17
5.6
4.9
mu/l
1.9
2.0
0.90
274
2343
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
213
1595
1.82
7.04
7.6
5.7
mmol/l
1.2
1.2
0.48
192
1423
(40761511) CBC panel - Blood by Automated count
334
2930
2.94
7.03
19.4
16.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
192
1396
1.80
6.98
6.4
5.3
%
58.3
58.6
0.12
166
1302
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
326
2835
2.59
6.82
5.9
5.2
mmol/l
6.0
6.1
0.48
289
2511
(3002030) Lymphocytes/100 leukocytes in Blood
193
1414
1.79
6.76
6.6
5.6
%
27.1
26.0
0.66
165
1302
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
269
2182
1.92
6.70
4.3
4.0
pmol/l
15.1
15.2
0.02
222
1911
(3019198) Lymphocytes [#/volume] in Blood
202
1503
1.78
6.68
6.4
5.3
e9/l
1.7
1.9
0.74
158
1322
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
319
2754
2.39
6.67
6.9
6.8
mmol/mol
40.0
41.1
1.50
289
2509
(3006315) Basophils [#/volume] in Blood
200
1488
1.77
6.58
6.5
5.2
e9/l
0.0
0.0
0.59
155
1281
(3013115) Eosinophils [#/volume] in Blood
204
1532
1.77
6.44
6.7
5.4
e9/l
0.2
0.2
0.79
159
1339
(3037467) Urinalysis macro (dipstick) panel - Urine
259
2102
1.83
6.11
4.9
4.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
197
1480
1.73
6.08
6.6
5.2
e9/l
0.6
0.6
0.63
152
1265
(3030467) Casts [#/volume] in Urine by Automated count
142
974
1.76
6.06
4.0
3.4
e6/l
0.5
0.6
0.03
118
742
(3044640) Blood type and Crossmatch panel - Blood
149
1038
1.74
6.01
2.4
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
91
558
1.84
5.59
3.9
3.3
e6/l
2.2
2.5
0.11
52
315
(3018095) Leukocytes [#/volume] in Urine
166
1209
1.69
5.59
4.8
4.1
e6/l
86.1
96.0
0.07
126
889
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
220
1731
1.70
5.50
7.8
6.4
mmol/l
1.2
1.2
0.52
183
1456
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
192
1460
1.68
5.44
2.1
2.2
pmol/l
94.5
93.8
0.07
94
732
(3021589) Normoblasts [#/volume] in Blood
178
1330
1.67
5.37
13.1
10.5
e9/l
0.0
0.0
0.76
138
1098
(3026493) Urate [Moles/volume] in Serum or Plasma
122
829
1.71
5.24
2.6
2.9
umol/l
8449.8
8751.2
0.02
95
685
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
157
1141
1.67
5.24
6.3
5.5
ug/l
3.0
4.3
0.63
134
994
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
147
2.45
5.19
3.2
2.9
g/l
1.3
0.8
0.28
26
125
(3002582) Erythrocytes [#/volume] in Urine
148
1063
1.67
5.14
4.0
3.6
e6/l
121.5
129.8
0.04
123
831
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
281
2387
1.81
5.12
8.5
7.6
u/l
80.1
80.5
0.05
257
2217
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
115
774
1.71
5.09
2.4
2.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
27
4.56
5.07
1.1
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
100
649
1.75
5.03
3.9
3.2
ug/l
0.9
0.8
0.26
76
458
(3013707) Erythrocyte sedimentation rate by Westergren method
266
2235
1.73
4.91
4.8
4.3
mm/h
14.9
14.9
0.01
244
2031
(3013650) Neutrophils [#/volume] in Blood by Automated count
216
1726
1.63
4.78
9.1
8.8
e9/l
3.9
4.3
2.19
174
1514
(3024561) Albumin [Mass/volume] in Serum or Plasma
190
1476
1.61
4.69
5.0
4.3
g/l
35.3
34.6
0.75
170
1369
(3002385) Erythrocyte distribution width [Ratio]
270
2290
1.72
4.67
26.9
21.8
%
13.8
13.9
1.24
265
2242
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
186
1439
1.61
4.66
4.6
4.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
164
1232
1.61
4.64
4.0
3.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
91
591
1.72
4.52
3.8
3.0
e6/l
1.5
1.2
0.23
52
345
(3020630) Protein [Mass/volume] in Serum or Plasma
58
334
1.88
4.28
2.9
3.0
g/l
65.0
65.9
0.30
51
296
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
155
2.24
4.21
2.3
2.6
g/l
3.1
3.2
0.08
24
122
(3000492) Spirometry study
44
234
2.00
4.10
1.8
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
30
138
2.28
4.02
2.3
2.7
g/l
36.1
37.0
0.32
23
116
(3015377) Calcium [Moles/volume] in Serum or Plasma
151
1150
1.54
3.83
3.1
3.2
mmol/l
2.4
2.3
0.22
120
975
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
158
2.13
3.63
2.2
2.6
g/l
10.5
10.1
0.19
24
133
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
290
1.84
3.61
2.1
2.4
u/l
27.5
32.0
0.74
41
237
(3026782) Osmolality of Urine
103
728
1.58
3.60
2.7
3.0
mosm/kgh2o
556.9
555.9
0.02
90
619
(3034860) Kappa light chains.free [Mass/volume] in Serum
29
139
2.18
3.54
3.3
4.4
mg/l
60.2
115.0
0.57
22
112
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
29
139
2.18
3.54
3.4
4.4
mg/l
55.8
55.7
0.00
22
112
(3018418) pH of Serum or Plasma
141
1072
1.52
3.54
7.0
3.8
ph
7.4
7.4
0.08
32
201
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
167
2.07
3.52
2.3
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
167
2.07
3.52
2.3
2.5
g/l
7.1
7.4
0.42
25
124
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
167
2.07
3.52
2.3
2.5
g/l
3.5
3.6
0.32
23
120
(3021960) Folate [Moles/volume] in Serum or Plasma
121
892
1.54
3.50
1.6
1.6
nmol/l
19.8
20.6
0.22
99
740
(3013512) EKG study
139
1058
1.51
3.45
4.2
4.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
200
1643
1.49
3.40
3.7
3.1
u/l
43.3
53.2
1.76
173
1491
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
59
368
1.72
3.34
3.6
3.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
45
259
1.84
3.33
4.0
4.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
163
1289
1.48
3.33
2.1
2.2
nmol/l
81.6
80.2
0.26
134
1112
(3032080) INR in Blood by Coagulation assay
182
1475
1.47
3.26
11.5
10.9
inr
1.3
1.3
0.54
55
418
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
55
340
1.73
3.22
3.2
2.7
umol/l
6.8
9.1
0.85
47
294
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
85
590
1.58
3.17
1.9
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
154
1217
1.46
3.10
3.6
2.7
ug/l
148.0
146.0
0.04
134
1091
(3007853) Bacteria identified in Skin by Aerobe culture
58
371
1.67
3.00
1.8
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
134
1038
1.46
2.96
1.9
2.1
u/l
170.2
219.3
0.37
123
971
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
35
3.21
2.95
1.4
1.1
u/ml
278.5
359.2
—
6
18
(40768795) Lymph node Pathology biopsy report
10
30
3.40
2.92
1.5
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
119
914
1.45
2.71
5.0
4.7
%
22.4
22.0
0.09
51
485
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
198
1668
1.42
2.69
6.1
6.1
umol/l
12.3
11.8
0.22
184
1582
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
159
1290
1.42
2.67
2.2
2.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
31
171
1.89
2.64
3.1
3.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
130
1021
1.43
2.61
3.6
3.1
mmol/l
6.6
6.8
0.22
101
828
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
38
2.95
2.60
1.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
38
2.95
2.60
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
246
2161
1.44
2.60
5.1
4.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
187
1.84
2.59
1.4
1.6
%
1.4
1.7
1.67
25
155
(40758558) Short blood count panel - Blood
102
769
1.46
2.54
7.1
6.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
20
96
2.15
2.48
4.1
4.9
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
21
3.87
2.47
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
65
450
1.54
2.44
1.3
1.3
iu/ml
24.1
46.1
0.97
15
145
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
15
64
2.40
2.42
1.3
1.3
—
2.0
—
0
11
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
45
286
1.66
2.40
4.9
3.4
ng/l
98.1
84.5
0.53
40
248
(3000850) Epithelial cells [#/volume] in Urine
100
759
1.44
2.39
2.6
2.7
e6/l
4.0
5.2
0.70
93
662
(3012516) Albumin [Mass/volume] in Urine
128
1017
1.40
2.37
3.7
3.2
mg/l
607.3
291.0
0.23
76
641
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
232
1.71
2.35
1.9
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
15
65
2.36
2.35
1.3
1.3
—
2.1
—
0
15
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
61
423
1.53
2.27
5.2
4.9
%
35.1
33.1
0.65
39
265
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
93
707
1.43
2.19
3.6
3.2
mmol/l
2.4
2.5
0.54
80
614
(3022145) Colonoscopy Study observation
53
360
1.55
2.17
1.4
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
37
2.75
2.12
1.0
1.1
nmol/l
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
133
1080
1.37
2.11
4.7
4.1
mg/mmol
5.7
8.7
0.70
72
678
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
146
1207
1.35
2.06
2.8
3.1
ng/l
2818.2
1584.7
0.57
124
1043
(3019225) pH of Specimen
50
341
1.54
2.01
3.3
4.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
216
1899
1.34
2.00
5.4
5.0
mmol/l
6.6
6.8
1.47
207
1782
(3017732) Neutrophils [#/volume] in Blood
31
188
1.71
1.98
2.0
2.8
e9/l
3.3
3.9
0.94
15
130
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
165
1.76
1.97
1.1
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
51
2.40
1.97
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
44
296
1.55
1.89
3.5
2.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
8
28
2.90
1.87
2.0
2.1
ug/l
2.0
1.6
—
8
23
(3006653) Thiamine [Moles/volume] in Blood
5
12
4.21
1.83
1.2
1.1
nmol/l
107.2
136.5
—
5
12
(3044941) Cell count panel - Synovial fluid
11
47
2.38
1.79
1.6
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
47
658
0.67
1.78
4.7
4.9
kg/l
1.0
1.0
—
9
93
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
61
2.17
1.73
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
43
294
1.53
1.73
10.3
8.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
75
2.04
1.72
3.1
2.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
55
2.22
1.69
1.7
2.3
pg
34.3
32.5
1.12
12
55
(3023368) Bacteria identified in Blood by Culture
121
997
1.32
1.69
5.3
4.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
69
524
1.39
1.62
2.2
2.9
mmol/l
0.8
0.8
0.21
62
486
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
15
77
1.99
1.61
3.6
2.1
g/l
3.0
3.8
1.41
15
72
(3003327) Ova and parasites identified in Stool by Light microscopy
15
78
1.96
1.56
1.4
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
84
663
1.35
1.56
2.0
1.7
mg/l
1.3
1.4
0.12
68
532
(3011397) Hemoglobin [Presence] in Urine by Test strip
88
703
1.33
1.51
3.9
4.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
58
2.11
1.51
1.4
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
37
2.47
1.49
1.6
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
72
559
1.36
1.48
1.2
1.2
u/ml
0.6
1.5
1.30
16
133
(3000475) Leukocytes [#/volume] in Synovial fluid
15
80
1.91
1.47
1.7
1.6
e6/l
12338.5
24266.2
—
6
58
(40768806) Pleura Pathology biopsy report
11
52
2.15
1.46
1.2
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
141
1.67
1.45
1.5
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
118
1.74
1.44
1.6
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
118
1.74
1.44
1.7
2.2
u/ml
0.3
0.4
—
6
64
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
39
2.34
1.44
1.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
40
2.28
1.41
1.7
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
40
2.28
1.41
1.6
1.3
—
—
—
0
0
(4094501)
14
74
1.93
1.41
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
23
2.64
1.37
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
24
2.52
1.31
1.3
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
18
107
1.72
1.28
1.5
1.7
—
136.0
—
0
5
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
25
2.42
1.25
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
19
2.65
1.22
1.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
19
2.65
1.22
1.0
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
64
504
1.33
1.21
2.6
1.6
g/l
2.8
2.6
0.10
32
276
(3003694) ABO and Rh group [Type] in Blood
83
678
1.29
1.21
1.4
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
54
416
1.35
1.18
2.1
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
58
452
1.34
1.18
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
49
373
1.36
1.16
1.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
20
2.52
1.15
1.0
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
46
347
1.37
1.15
2.8
2.7
e9/l
63.9
68.2
0.45
32
281
(3026008) Bacteria identified in Urine by Culture
130
1130
1.24
1.12
3.1
3.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
41
1.97
1.09
1.1
2.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
21
2.40
1.09
2.0
2.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
165
1474
1.22
1.09
4.0
4.3
estimate
0.0
0.0
0.00
33
287
(3019309) Folate [Moles/volume] in Red Blood Cells
92
774
1.25
1.06
1.9
1.8
nmol/l
1258.3
1189.8
0.20
57
575
(40761535) Cells panel - Urine sediment
18
274
0.64
1.05
4.2
3.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
46
1.98
1.04
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
46
1.98
1.04
3.2
4.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
167
1500
1.21
1.03
4.1
4.4
estimate
0.0
0.0
0.00
34
272
(3021601) Nitrite [Presence] in Urine by Test strip
165
1482
1.21
1.01
5.6
5.8
estimate
0.0
0.0
0.00
35
281
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
37
276
1.38
1.00
1.2
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
35
2.02
1.00
2.0
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
35
2.02
1.00
1.4
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
92
1.66
0.98
1.5
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
57
456
1.30
0.98
2.7
2.5
%
1.6
1.8
1.35
47
408
(4062490)
5
23
2.19
0.98
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
11
62
1.80
0.95
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
201
1.43
0.94
3.1
2.6
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
37
1.91
0.94
1.1
1.4
u/l
923.6
259.7
—
7
37
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
28
2.16
0.92
1.0
1.5
—
53.3
—
0
6
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
416
1.29
0.90
2.1
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
154
1386
1.19
0.90
3.9
4.1
ng/l
38.8
43.5
0.24
120
1099
(3012441) Differential panel - Pleural fluid
8
43
1.88
0.88
1.4
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
113
991
1.20
0.87
2.7
2.3
u/l
63.5
57.8
0.27
101
912
(3014271) Vancomycin [Susceptibility]
6
30
2.02
0.87
2.0
2.6
—
—
—
0
0
(3000012) Reticulocyte production index
6
30
2.02
0.87
1.0
2.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
64
1.74
0.87
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
80
1.65
0.85
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
80
1.65
0.85
1.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
88
1.61
0.85
1.5
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
129
1.50
0.85
1.5
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
45
1.80
0.85
1.8
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
57
1.78
0.84
1.7
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
421
1.27
0.83
1.2
1.3
u/ml
31.0
17.5
—
10
146
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
46
1.76
0.83
3.6
2.5
e9/l
3.3
5.0
—
8
46
(40768793) Breast Pathology biopsy report
12
73
1.67
0.82
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
9
149
0.59
0.80
5.2
4.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
66
1.69
0.79
2.1
3.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
25
0.00
0.79
0.0
4.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
62
517
1.24
0.78
4.2
2.4
g/l
2.2
2.3
0.54
57
472
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
34
1.78
0.76
1.0
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
75
1.62
0.76
1.2
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
116
1.49
0.75
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
55
1.65
0.74
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
35
275
1.30
0.71
2.1
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
59
495
1.23
0.71
4.5
2.4
%
21.0
21.3
0.08
54
423
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
26
1.94
0.71
2.2
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
31
240
1.32
0.70
2.9
4.1
%
0.6
0.5
—
7
68
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
77
1.58
0.69
1.5
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
42
1.68
0.68
1.0
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
27
1.86
0.68
3.6
3.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
37
295
1.28
0.68
1.6
2.1
ug/g
94.2
165.3
1.14
26
230
(3047181) Lactate [Moles/volume] in Blood
5
92
0.54
0.68
5.6
5.4
mmol/l
0.9
1.2
—
5
87
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
94
1.51
0.67
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
43
1.64
0.67
1.1
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.0
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
70
1.59
0.66
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
95
1.49
0.65
1.2
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
5
29
1.73
0.64
1.0
1.0
ng/l
33.8
33.3
—
5
13
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
5
29
1.73
0.64
1.0
1.0
ng/l
563.4
510.9
—
5
14
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
29
1.73
0.64
1.0
1.0
ng/l
217.0
248.0
—
5
13
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
49
1.65
0.62
1.9
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
96
1.48
0.62
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
66
569
1.20
0.62
4.5
5.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
50
1.61
0.61
4.0
3.2
%
60.6
61.8
—
8
50
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
20
0.00
0.60
0.0
3.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
26
202
1.31
0.59
2.0
3.6
mmol/l
2.0
2.2
0.17
18
159
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
53
1.52
0.59
2.1
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
13
184
0.70
0.58
1.8
3.1
mmol/l
26.0
25.1
1.02
13
179
(3000093) Morphology [Interpretation] in Blood Narrative
6
35
1.73
0.58
1.3
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
36
1.68
0.57
1.7
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
73
1.52
0.57
1.7
2.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
38
1.59
0.54
2.0
2.5
nmol/l
13.4
7.8
—
6
38
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
74
1.50
0.54
1.6
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
74
1.50
0.54
1.1
1.3
—
—
—
0
0
(3012544) pH of Venous blood
43
361
1.22
0.53
4.3
3.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
66
1.53
0.53
2.3
2.1
%
57.7
59.9
—
10
66
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
66
1.53
0.53
2.5
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
28
345
0.80
0.51
2.0
2.5
ug/l
7.6
6.5
0.09
23
302
(3025159) Blasts/100 leukocytes in Blood
30
243
1.26
0.51
3.1
4.3
%
0.0
1.3
—
6
74
(4010399)
28
226
1.26
0.50
1.3
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
64
563
1.17
0.49
4.1
2.3
umol/l
11.8
12.2
0.24
59
514
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
93
1.41
0.49
1.2
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
98
891
1.14
0.48
2.3
2.2
mg/l
2.9
3.2
0.95
79
762
(3045142) Bone marrow Pathology biopsy report
7
47
1.50
0.48
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
47
1.50
0.48
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
47
404
1.19
0.47
3.7
4.0
ug/l
4.7
36.7
1.01
35
343
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
129
1.33
0.46
2.9
3.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
20
253
0.78
0.46
2.9
4.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
39
331
1.20
0.45
1.5
1.3
titre
226.7
497.1
—
6
70
(1761868) Lipid panel - Serum or Plasma
86
779
1.14
0.45
3.5
3.6
—
—
—
0
0
(44790047)
5
33
1.52
0.41
1.0
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.0
1.7
—
—
—
0
0
(44790049)
5
33
1.52
0.41
1.0
1.4
—
—
—
0
0
(44790048)
5
33
1.52
0.41
1.0
1.4
—
—
—
0
0
(44806118)
5
33
1.52
0.41
1.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
105
1134
0.90
0.40
4.4
4.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
60
1.34
0.40
1.3
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
34
1.48
0.40
1.4
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
193
0.77
0.40
2.5
4.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
35
1.43
0.39
1.6
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
35
1.43
0.39
1.2
3.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
75
681
1.13
0.38
3.9
3.9
ng/l
117.8
192.1
0.43
68
589
(3023183) Ammonium ion [Moles/volume] in Plasma
9
69
1.31
0.37
2.2
1.9
umol/l
26.3
29.5
—
9
56
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
41
1.47
0.36
1.0
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
227
1.20
0.35
2.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
42
1.44
0.35
1.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
42
1.44
0.35
1.0
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
42
1.44
0.35
3.7
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
164
1.23
0.33
2.6
3.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
257
1.18
0.33
3.1
4.2
%
0.0
0.1
—
6
85
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
38
333
1.16
0.32
2.0
3.0
ng/l
304.4
244.5
0.22
32
304
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
211
1.20
0.32
1.7
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
52
1.35
0.31
1.1
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
33
377
0.86
0.31
10.0
7.4
%
96.6
95.4
1.38
33
370
(3042631) Mycobacterium sp identified in Specimen
7
54
1.30
0.30
2.7
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
84
780
1.10
0.29
1.9
1.8
pmol/l
150769682.7
18690539.1
0.41
65
626
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
56
1.25
0.29
1.1
1.1
mmol/l
3.5
3.8
—
7
50
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
177
1.20
0.28
10.8
8.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
38
426
0.88
0.28
9.2
6.9
kpa
5.2
5.1
0.31
38
411
(3027801) Oxygen [Partial pressure] in Arterial blood
38
426
0.88
0.28
9.1
6.9
kpa
12.2
11.5
0.44
38
412
(3003396) Base excess in Arterial blood by calculation
38
426
0.88
0.28
8.9
7.0
mmol/l
1.0
1.4
0.22
33
344
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
10
77
1.31
0.26
1.2
1.6
mg/l
13.4
14.1
—
10
71
(3022621) pH of Urine by Test strip
19
224
0.84
0.26
3.8
3.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
54
496
1.10
0.24
2.4
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
84
789
1.08
0.24
3.5
4.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
(4146454)
5
38
1.32
0.23
2.2
3.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
38
1.32
0.23
2.0
1.1
—
—
—
0
0
(4034850)
7
95
0.73
0.22
12.9
13.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.0
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
1076.4
—
0
10
(3028707) Methadone [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
12
0.00
0.21
0.0
4.4
—
49.0
—
0
12
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
32.9
—
0
8
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.3
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
88.8
—
0
8
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
114
0.78
0.20
1.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.3
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
18
156
1.16
0.19
1.4
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
14
164
0.85
0.18
1.4
1.7
ug/l
0.5
3.7
—
9
141
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
58
1.21
0.18
1.3
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
93
887
1.07
0.18
3.4
2.8
u/l
94.7
31.1
0.52
86
846
(3052851) Hemolysis interference index of Serum or Plasma
13
110
1.19
0.17
4.3
3.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
21
187
1.13
0.16
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
30
274
1.10
0.16
3.2
4.1
%
0.5
1.0
—
8
95
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
103
1.17
0.14
1.5
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
103
1.17
0.14
1.3
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
262
0.91
0.13
1.5
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.4
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
44
1.14
0.10
2.4
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
421
0.94
0.09
6.2
8.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
48
1.04
0.09
1.4
1.8
%
90.7
89.2
—
5
48
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
243
1.08
0.09
2.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
55
1.09
0.09
1.0
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
107
1.13
0.08
1.5
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
58
1.04
0.08
1.7
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
61
0.82
0.08
14.4
2.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
66
1.06
0.08
1.4
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
68
1.03
0.08
1.3
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
75
0.80
0.07
1.0
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
245
1.07
0.07
2.7
3.1
ml/min/173m2
53.3
55.1
0.10
13
105
(3037756) Immunofixation for Serum or Plasma
10
90
1.11
0.05
1.8
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
90
1.11
0.05
1.5
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
248
1.05
0.05
1.9
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
82
832
0.98
0.03
4.6
4.7
estimate
0.0
0.0
0.00
33
268
(3014576) Chloride [Moles/volume] in Serum or Plasma
46
467
0.98
0.01
8.6
6.7
mmol/l
104.0
103.9
0.04
46
457
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
151
0.99
0.00
1.7
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
283
0.99
0.00
1.3
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
169.4
—
0
9
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
79
1.01
0.00
1.3
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
73
0.96
0.00
1.0
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
67
0.89
0.00
1.3
2.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.5
—
3082.0
—
0
6
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
1.0
—
0
6
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
2.8
—
14.1
—
0
6
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.0
—
1.2
—
0
6
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
88
0.91
0.00
1.9
1.3
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
50
1.00
0.00
1.4
1.7
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_MELANOMA_FACE – Melanoma in situ of other and unspecified parts of face

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).